Heart Failure in Thyrotoxic Cardiomopathy: Extracorporeal Membrane Oxygenation Treatment for Graves' Disease
- PMID: 26834286
- PMCID: PMC4730167
Heart Failure in Thyrotoxic Cardiomopathy: Extracorporeal Membrane Oxygenation Treatment for Graves' Disease
Abstract
Thyrotoxicosis-induced cardiomyopathy and consequent heart failure is one of the most grave complications of uncontrolled hyperthyroidism. In such patients, early recognition of thyrotoxicosis, and directed antithyroid therapy can lead to rapid normalization of left ventricular function. Herein, we present a case of a 29-year-old male with Graves' disease who developed heart failure with severe deterioration of left ventricular function and eventually, circulatory collapse. Height and weight of the patient were 1.8 m and 84 kg, respectively. The patient was placed on venoarterial extracorporeal membrane oxygenation for immediate circulatory support, with restoration of cardiac function after 6 days.
Keywords: cardiomyopathy; extracorporeal membrane oxygenation; heart failure; hyperthyroidism; thyrotoxicosis.
Conflict of interest statement
The senior author has stated that the authors have reported no material, financial, or other relationship with any healthcare-related business or other entity whose products or services are discussed in this paper.
References
-
- Nayak B, Burman K.. Thyrotoxicosis and thyroid storm. Endocrinol Metab Clin North Am. 2006;35:663–86. - PubMed
-
- Klein I, Kaie O.. Thyroid hormone and the cardiovascular system. N Engl J Med. 2001;344:501–9. - PubMed
-
- Brain SD, Grant AD.. Vascular actions of calcitonin gene-related peptide and adrenomedullin. Physiol Rev. 2004;84:903–34. - PubMed
-
- Dahl P, Danzi S, Klein I.. Thyrotoxic cardiac disease. Curr Heart Fail Rep. 2008;5:170–6. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical